hypertension. Other disorders of blood and blood-forming organs in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Control group: There is not any intervention in control group. Intervention 2: Instructions for the experimental group last for three months during which the researcher will hold sessi
Treatment - Drugs
Prevention
Control group: There is not any intervention in control group.
Instructions for the experimental group last for three months during which the researcher will hold sessions of question and answer with the subjects .They take part in discussions for fifteen session
Sponsors
Vice-chancellor for research-Hamedan University of Medical Sciences
Vice-chancellor for research-Sabzevar University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Sabzevar residency; eager to participate on the project; having an age of more than 20 Exclusion criteria:any refusal to cooperate with the researcher; hospitalization; immigration
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hypertension. Timepoint: The beginning of descriptive study,At the beginning of intervention,3 months after the intervention, 6 months after intervention. Method of measurement: hypertension high blood pressure according to the millimeters Mercury with the use of digital indicator and the manner of measuring blood pressure blood pressure on a scale will be dysfunction. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart attack and a stroke. Timepoint: 3 months after the intervention, and 6 months after treatment. Method of measurement: Observation and measurement of systolic blood pressure. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDelawari Heravi Maryam
Hamedan University of Medical Sciences
Outcome results
None listed